Nugeyre Marie-Thérèse, Monceaux Valérie, Beq Stéphanie, Cumont Marie-Christine, Ho Tsong Fang Raphaël, Chêne Laurent, Morre Michel, Barré-Sinoussi Françoise, Hurtrel Bruno, Israël Nicole
Unité de Biologie des Rétrovirus Institut Pasteur, Paris, France.
J Immunol. 2003 Oct 15;171(8):4447-53. doi: 10.4049/jimmunol.171.8.4447.
The main failure of antiretroviral therapy is the lack of restoration of HIV-specific CD4(+) T cells. IL-7, which has been shown to be a crucial cytokine for thymopoiesis, has been envisaged as an additive therapeutic strategy. However, in vitro studies suggest that IL-7 might sustain HIV replication in thymocytes and T lymphocytes. Therefore, in the present study, we evaluated the effect of IL-7 on both T cell renewal and viral load in SIVmac-infected young macaques in the absence of antiretroviral therapy. This evaluation was conducted during the asymptomatic phase in view of a potential treatment of HIV patients. We show that IL-7 induces both a central renewal and a peripheral expansion of T lymphocytes associated with cell activation. No alarming modulation of the other hemopoietic cells was observed. No increase in the viral load was shown in blood or lymph nodes. These data strengthen the rationale for the use of IL-7 as an efficient immunotherapy in AIDS.
抗逆转录病毒疗法的主要失败之处在于无法使HIV特异性CD4(+) T细胞恢复。白细胞介素-7(IL-7)已被证明是胸腺生成的关键细胞因子,被设想为一种辅助治疗策略。然而,体外研究表明,IL-7可能会维持HIV在胸腺细胞和T淋巴细胞中的复制。因此,在本研究中,我们评估了在未进行抗逆转录病毒治疗的情况下,IL-7对感染SIVmac的年轻猕猴T细胞更新和病毒载量的影响。鉴于对HIV患者的潜在治疗,该评估在无症状期进行。我们发现,IL-7可诱导与细胞活化相关的T淋巴细胞的中枢更新和外周扩增。未观察到其他造血细胞有令人担忧的调节变化。血液或淋巴结中的病毒载量未显示增加。这些数据强化了将IL-7用作艾滋病有效免疫疗法的理论依据。